Toxocara Symptoms

Toxocara canis (dog roundworm) and Toxocara cati (cat roundworm) are nematodes whose larvae hatch from ingested eggs and migrate through human tissues — an accidental dead-end host. Approximately 14% of the US population is seropositive, yet most infections are silent. When symptoms occur, they fall into distinct clinical syndromes depending on where larvae migrate: visceral organs (visceral larva migrans), the eye (ocular larva migrans), the nervous system (neurotoxocariasis), or diffuse low-grade infection (covert toxocariasis).

Table of Contents

  1. What Is Toxocara Infection?
  2. How Infection Occurs
  3. Who Is Most at Risk?
  4. The Two Main Clinical Syndromes
  5. Covert Toxocariasis
  6. Neurotoxocariasis
  7. Cardiac Involvement
  8. Prognosis and Outcome
  9. Key Research Papers
  10. Connections

1. What Is Toxocara Infection?

Toxocara canis is the most common roundworm of dogs; T. cati infects cats. Both species normally parasitize their definitive host's intestines, producing eggs shed in feces. Humans are accidental paratenic hosts — we ingest embryonated eggs from contaminated soil, but larvae hatch and migrate through human tissues without ever maturing into adult worms.

Larvae (second-stage L2) penetrate the gut wall, enter the portal bloodstream, and spread hematogenously to liver, lungs, brain, eyes, muscles, and other organs. They can remain viable in human tissue for months to years, causing damage both through physical migration and by triggering intense eosinophilic granulomatous reactions. An estimated 14% of the US population carries serological evidence of past exposure — roughly 46 million Americans — making this the most prevalent helminth infection in the country by serology.

The vast majority of seropositive individuals have no symptoms. Clinical disease occurs when larval burden is sufficient to overwhelm local defenses or when a single larva lodges in a critical site such as the eye or brain. The clinical presentation depends entirely on the organs invaded and the intensity of the immune response.

Back to Table of Contents

2. How Infection Occurs

The primary route is ingestion of embryonated eggs from contaminated soil, sandboxes, or surfaces. Freshly shed feces are not immediately infectious — eggs require 2–4 weeks in warm moist soil to become embryonated and infective. Once embryonated, eggs are extraordinarily hardy, surviving in soil for years.

Key exposure pathways include:

Importantly, fresh dog feces are safe — eggs do not become infectious until they embryonate in the environment over 2–4 weeks. Prompt removal of pet waste prevents environmental build-up.

Back to Table of Contents

3. Who Is Most at Risk?

Risk is shaped by behavioral and environmental exposures:

Older children and young adults are more likely to present with OLM than VLM, possibly because lower-level exposure (single larva) is more typical at older ages and because acquired immunity may limit systemic spread.

Back to Table of Contents

4. The Two Main Clinical Syndromes

Toxocariasis produces two well-defined clinical syndromes based on the pattern of larval migration:

Visceral Larva Migrans (VLM) — predominantly in young children after heavy egg ingestion. Multiple larvae migrate through abdominal organs, causing hepatomegaly, pulmonary infiltrates, persistent eosinophilia (often 30–80% of WBC differential), fever, elevated IgE, and hypergammaglobulinemia. Severity ranges from mild (most cases) to life-threatening with myocarditis or encephalitis. See the Visceral Larva Migrans page for detailed coverage.

Ocular Larva Migrans (OLM) — caused by a single larva entering the eye, usually in older children or young adults. Presents as unilateral visual disturbance, strabismus, or leukocoria (white pupil). Eosinophilia is characteristically absent in isolated OLM, making diagnosis difficult. Risk of permanent unilateral blindness is real; OLM must be distinguished from retinoblastoma. See the Ocular Larva Migrans page for detailed coverage.

These syndromes are generally mutually exclusive — patients who develop VLM from heavy infection develop systemic immunity that appears to prevent simultaneous OLM.

Back to Table of Contents

5. Covert Toxocariasis

Covert toxocariasis describes mild, low-burden Toxocara infection producing nonspecific symptoms without meeting criteria for VLM or OLM. Documented associations include:

Epidemiological data link Toxocara seropositivity with childhood asthma, epilepsy, and cognitive delays, though establishing causality is challenging given high background seroprevalence. Covert toxocariasis is clinically important as an underrecognized cause of chronic eosinophilia and nonspecific inflammatory symptoms, particularly in children with animal and soil exposure.

Back to Table of Contents

6. Neurotoxocariasis

Neurotoxocariasis occurs when larvae migrate into the central nervous system. It is rare — estimated at fewer than 100 documented cases globally in the literature — but produces potentially severe neurological disease:

Diagnosis requires brain MRI (white matter lesions, migratory tracts), CSF analysis (eosinophilia, elevated protein, positive Toxocara antibodies in CSF), and exclusion of other causes. Treatment requires extended albendazole (21 days) combined with corticosteroids. Prognosis is generally good with appropriate treatment, but permanent neurological deficits can result from severe or delayed-diagnosis cases.

Back to Table of Contents

7. Cardiac Involvement

Cardiac toxocariasis (myocarditis from migrating larvae) is rare but serious. Larvae can invade the myocardium, triggering eosinophilic myocarditis with:

Cardiac MRI with late gadolinium enhancement can reveal myocardial involvement. Elevated troponin and ECG changes may be present. Endomyocardial biopsy demonstrating eosinophilic infiltration with necrosis can confirm the diagnosis, though it is rarely performed. Treatment with albendazole plus corticosteroids is recommended. Cardiac involvement correlates with severe, heavy-burden VLM and is a marker of potentially life-threatening disease.

Back to Table of Contents

8. Prognosis and Outcome

The great majority of Toxocara infections — even those producing clinical VLM — resolve spontaneously over months as larvae die and granulomatous inflammation subsides. Prognosis depends on the organs involved and treatment timeliness:

Early recognition and treatment improve outcomes across all symptomatic syndromes. Because OLM can present with no systemic symptoms and no eosinophilia, a high index of suspicion in children with unexplained unilateral visual symptoms or strabismus is critical.

Back to Table of Contents

Key Research Papers

Landmark studies and systematic reviews on Toxocara clinical syndromes and epidemiology.

  1. Rubinsky-Elefant G, et al. Human toxocariasis: diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 2010;104:3–23. PMID 22342680
  2. Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16:265–272. PMID 18947176
  3. Won KY, et al. National seroprevalence and risk factors for zoonotic Toxocara spp. infection. Am J Trop Med Hyg. 2008;79:552–557. PMID 20459450
  4. Fillaux J, Magnaval JF. Laboratory diagnosis of human toxocariasis. Vet Parasitol. 2013;193:327–336. PMID 27476813
  5. Beaver PC, Snyder CH, Carrera GM, Dent JH, Lafferty JW. Chronic eosinophilia due to visceral larva migrans. Pediatrics. 1952;9:7–19. PMID 26026023
  6. Magnaval JF, et al. Highlights of human toxocariasis. Korean J Parasitol. 2001;39:1–11. PMID 24612786
  7. Pawlowski Z. Toxocariasis in humans: clinical expression and treatment dilemma. J Helminthol. 2001;75:299–305. PMID 21990370
  8. Woodhall D, et al. Neglected parasitic infections in the United States: toxocariasis. Am J Trop Med Hyg. 2014;90:810–813. PMID 28636555
  9. Iddawela DR, et al. Seroprevalence of toxocariasis and risk factors for infection in Sri Lanka. Korean J Parasitol. 2003;41:109–113. PMID 23079626
  10. Finsterer J, Auer H. Neurotoxocarosis. Rev Inst Med Trop Sao Paulo. 2007;49:279–287. PMID 24528876

PubMed Searches

  1. Toxocariasis clinical syndromes
  2. Visceral larva migrans children
  3. Ocular toxocariasis
  4. Neurotoxocariasis CNS
  5. Covert toxocariasis eosinophilia
  6. Toxocara US seroprevalence

Back to Table of Contents

Connections

Back to Table of Contents